HomeCATX • NYSEAMERICAN
add
Perspective Therapeutics Inc
$4.40
Pre-market:(9.32%)+0.41
$4.81
Closed: Nov 27, 8:06:45 AM GMT-5 · USD · NYSEAMERICAN · Disclaimer
Previous close
$3.69
Day range
$3.98 - $4.64
Year range
$2.28 - $19.05
Market cap
278.99M USD
Avg Volume
1.69M
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 369.00K | 33.70% |
Operating expense | 19.00M | 89.54% |
Net income | -15.12M | -46.02% |
Net profit margin | -4.10K | -9.22% |
Earnings per share | -0.21 | -13,900.00% |
EBITDA | -17.96M | -89.66% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 267.85M | 1,389.45% |
Total assets | 391.15M | 253.93% |
Total liabilities | 62.68M | 433.55% |
Total equity | 328.47M | — |
Shares outstanding | 67.59M | — |
Price to book | 0.76 | — |
Return on assets | -11.99% | — |
Return on capital | -13.75% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -15.12M | -46.02% |
Cash from operations | 3.37M | 133.29% |
Cash from investing | -29.74M | -13,000.00% |
Cash from financing | 628.00K | 62,700.00% |
Net change in cash | -25.74M | -149.06% |
Free cash flow | -22.39M | -261.90% |
About
Isoray Inc. is a national isotope-based medical company and the sole producer of Cesium brachytherapy sources, which are expanding brachytherapy treatments for difficult to treat cancers. Isoray is a registered manufacturer with the FDA and holds multiple 510 clearances for brachytherapy devices. The brachytherapy isotopes are sold under the brandname Blu.
The company went public in 2005. Isoray’s corporate headquarters is located at 350 Hills Street, Suite 106, Richland WA 99354. Wikipedia
Founded
2004
Headquarters
Website
Employees
116
